Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Intensified Adjuvant Chemo No Better Than Standard in High-Risk Colon Cancer

(MedPage Today) -- Intensified adjuvant chemotherapy did not improve disease-free survival (DFS) compared with standard chemotherapy in patients with high-risk stage III colon cancer, the phase III IROCAS trial showed. The 3-year DFS rate was...

Intensified Adjuvant Chemo No Better Than Standard in High-Risk Colon Cancer

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 29 October →